menu

High-Risk Non-muscle Invasive Bladder Cancer (NMIBC)

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Exploring High-Risk Non-muscle Invasive Bladder Cancer (NMIBC)

Program Information
Recommended

Program Information

ReachMD Healthcare Image
RestartResume

From prevalence to prognosis, explore a leading physician’s perspective on high-risk non-muscle invasive bladder cancer. 

  • Sponsored by

  • Overview

    Dr. Gary Steinberg from the NYU Grossman School of Medicine gives an in-depth overview of high-risk non-muscle invasive bladder cancer. Bladder cancer was estimated to be the sixth most prevalent cancer in the United States in 2021. In fact, an estimated 83,730 people were diagnosed with bladder cancer in 2021 alone, and of newly detected cases, approximately 75% are non-muscle invasive bladder cancer.

    Copyright © 2022 Merck & Co., Inc., Rahway, NJ, USA and its affiliates. All rights reserved.
    US-NMI-00437 06/22

Schedule26 Jun 2022
Webpack App